Should you buy RBS shares?

The government is quietly selling its stake in RBS, the bank it bailed out at a cost of £45bn. Here, Matthew Partridge looks at whether the shares are worth buying.

150807-RBS-cash-machines

RBS shares might be worth a gamble

Earlier this week the government quietly sold around 6% of RBS, the bank it bailed out in 2008.

This decision has been controversial. Several commentators pointed out that the current price means that the taxpayer will make a £1bn loss on the sale.

While few people argue that RBS should be kept in state hands for the long term, the decision to sell it at the current price has raised eyebrows, especially since it were much higher only a few months ago.

Indeed, there are mutterings that some hedge funds may have found out about the surprise sale beforehand and shorted the shares, further depressing the price.

But none of that matters to investors. The only thing that they should care about is whether the shares are worth buying at the current price.

We think RBS shares might be worth a gamble.

RBS has a chequered history

Under its chief executive, Fred Goodwin, RBS expanded at a rate that was aggressive even compared to its competitors. In 2007, it bought part of Dutch bank ABN Amro and became the biggest bank in the world, with assets of £1.9trn.

This meant that RBS became massively overextended just as the flow of money was drying up. The government forced it to raise extra capital from the market, but this failed. The taxpayer was forced to step in at a cost of £45bn, and ended up with a 79% stake in the bank. Goodwin was removed as CEO in October 2008.

RBS goes on a diet

As part of this, the bank slimmed down drastically. It has sold off over 600 UK branches, plus Coutts, its private bank. Other sales include its insurance business and German operations.

Overall assets are down by nearly half from their peak levels, and expected to fall further. Normally such actions would be a big negative. But in this case it should help RBS become a much more stable and focused institution.

It is also having an immediate effect on the bottom line. The bank unexpectedly made a profit last year, and recent results were also extremely positive.

The end of state control

So the good news from this week's sale is that it shows George Osborne is eager to move RBS back to the private sector as soon as possible a goal he will be eager to accomplish given his ambitions to succeed David Cameron as prime minister.

Importantly, studies have shown that investing in newly privatised companies can be a smart move. Around two-thirds of the companies that were sold off in the 1980s and 1990s outperformed the market.

While a few shares, such as BT and British Airways, haven't done so well, others, including BAA and British Gas, proved lucrative. Indeed, one company, Amersham International (a medical device group sold off in 1982) produced huge returns for shareholders when it was bought by General Electric for £5.7bn in 2002.

It's clear that professional managers answering to shareholders are far better at running a company than civil servants or government-appointed trustees.

Governments are also bad at selling assets. Since a failed privatisation leads to a lot of bad PR, they tend to be undervalued as with the botched sale of Royal Mail in 2013. The state also has a knack of selling when the market is at its lowest point, as it did with gold between 1998 and 2002.

Litigation risk priced in

However, these concerns seem overstated. Litigation is a problem for the entire sector, rather than RBS specifically. RBS is also looking to sell its stake in US subsidiary Citizens' Financial Group, which should further reduce its legal exposure. It's hard to see how even the most aggressive legal costs could exceed the $10bn that the bank has already set aside.

In any case, these risks are outweighed by the fact that it is valued at an attractive rate. RBS (LSE: RBS) currently trades at 12.8 times forward earnings, and at a discount of 30% to its reported net assets. Even when these assets are valued more conservatively, there is still a 10% discount.

Recommended

An investment trust that gives exposure to frontier markets
Investment trusts

An investment trust that gives exposure to frontier markets

An investment trust investing in small, illiquid emerging markets has disappointed, but deserves another chance, says Max King
26 Oct 2021
Get healthy returns from these three healthcare stocks
Share tips

Get healthy returns from these three healthcare stocks

Professional investor Paul Major of the BB Healthcare Trust highlights three of his favourite healthcare stocks.
25 Oct 2021
Back on track: why you should invest in railways
Share tips

Back on track: why you should invest in railways

Rail transport suffered a severe blow in the pandemic. But while post-Covid-19 working patterns may reduce revenue, trends in technology, long-distanc…
22 Oct 2021
Airtel Africa has growth on speed dial. Here's how to play it
Trading

Airtel Africa has growth on speed dial. Here's how to play it

Mobile-phone group Airtel Africa is cashing in on the rise of the continent's digital economy and looks set for years of rapid expansion, says Matthew…
22 Oct 2021

Most Popular

Properties for sale for around £1m
Houses for sale

Properties for sale for around £1m

From a stone-built farmhouse in the Snowdonia National Park, to a Victorian terraced house close to London’s Regent’s Canal, eight of the best propert…
15 Oct 2021
How to invest as we move to a hydrogen economy
Energy

How to invest as we move to a hydrogen economy

The government has started to roll out its plans for switching us over from fossil fuels to hydrogen and renewable energy. Should investors buy in? St…
8 Oct 2021
Emerging markets: the Brics never lived up to their promise – but is now the time to buy?
Emerging markets

Emerging markets: the Brics never lived up to their promise – but is now the time to buy?

Twenty years ago hopes were high for Brazil, Russia, India and China – the “Brics” emerging-market economies. But only China has beaten expectations. …
18 Oct 2021